Skip to main content
BETA logo

BETA · BETA Technologies, Inc.

Track BETA — free
$22.20 +1.39 (+6.68%) At close · Sep 4
Market Cap
$5.19B
Shares
233.94M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$22.20 Open$21.15 Day$20.94–22.62 Available close range$13.59–36.80 Avg vol 30d2.0M Short int8.6M · 3.7% float · 4.0d Short vol57% Last earningsAug 12, 2026 DataNov 2025–Sep 2026 Filing10-Q · Aug 12

The closing range uses available history since Nov 4, 2025; less than a full year is stored.

Up next

Next earnings call
Nov 12, 2026 Est · unconfirmed · in 10 wks
filed Aug 12, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$44.84M
Trailing 12 months
Net income (TTM)
−$858.24M
Trailing 12 months
Revenue growth YoY
+145.7%
Year over year
Operating margin
-1,129.3%
Trailing 12 months
P / E (TTM)
Trailing earnings
FCF yield
-8.1%
TTM · current market cap
Return on invested capital
Trailing 12 months
Net cash
$1.30B
Latest balance sheet
Dividend yield
Trailing 12 months
Shares change YoY
+406.1%
Year over year · more shares
Price change (1Y)
Trailing year
Short interest
3.7%
Latest settlement · 4.0 days to cover
View all 114 metrics

AI Brief

Q2 FY26 earnings call · Aug 12, 2026
Q2 FY26

TL;DR. BETA reported Q2 revenue of $14.7M (more than double year-ago), raised full-year 2026 revenue guidance to $42–50M and updated Adjusted EBITDA guidance to ($400)–($445)M, while posting a $148.8M net loss. Operating highlights included first-ever eIPP flights, the MV250 unveiling with GE, FAA certification progress on the H500A and CX300, and an expanded backlog over 1,000 aircraft including a Loganair term sheet for five CX300s.

Bullish
  • + Q2 revenue rose to $14.7M from $6.0M a year ago
  • + Raised full-year 2026 revenue guidance to $42–50M
  • + Backlog exceeds 1,000 aircraft with a roughly 50/50 CTOL/VTOL mix and added a Loganair term sheet for five CX300s
  • + Achieved industry-first eVTOL Integration Pilot Program flights transporting organs with United Therapeutics
  • + Unveiled MV250 hybrid-electric autonomous VTOL with GE; demonstrated first high-altitude hybrid-electric flight above 30,000 feet
  • + Cash and equivalents of $1.48B and XM financing to extend runway and fund CapEx
Bearish
  • Q2 net loss widened to $148.8M from $80.4M and Adjusted EBITDA loss widened to ($109.8)M from ($68.4)M
  • R&D spend more than doubled year-over-year to $122.4M, pressuring losses
  • Full-year 2026 Adjusted EBITDA guided to a wider loss range of ($400)–($445)M

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Buy Momentum Neutral Sentiment Neutral Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 14.5 · calm Equity put/call 0.58
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +8%
above
Price vs 50-day avg +9%
above
RSI (14) 52
neutral
MACD trend Negative
52-week position 37%
mid-range
Momentum
relative strength
Neutral
1-month return −6%
trailing
6-month return +32%
trailing
YTD return −21%
this year
Relative strength +17%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $20 › 200d $21 — 200d above 50d
Institutional flow Accumulating
+30% holders QoQ · +72 funds added
Insider flow Accumulating
Net +$502.8K over 90 days · 0% sells
Short interest Rising
3.66% of float · ▲ +9.4% MoM · 4.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
191 holders — 13F breadth
Squeeze score 56
elevated · 0–100
Fundamentals
Strong
Revenue growth +136%
Y/Y
Gross margin 72%
expanding
EPS growth −90%
Y/Y
Free cash flow $-313.2M
Balance sheet $1.5B
net cash
Quant / Vol
risk profile
Very High
Volatility 77%
annualized · 1-yr
Max drawdown −63%
past year
ATR 7.1%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the 8-K filed Aug 12, 2026
Full year 2026 revenues · full year 2026 Initiated $42M – $50M
prior FY $35.62M midpoint +29.2% Y/Y
Full year 2026 Adjusted EBITDA · full year 2026 Initiated $-445M – $-400M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
1 · 3 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+8% Bullish
Price vs 50-day avg
+9% Bullish
RSI (14)
52 Neutral
MACD trend
Negative Bearish
52-week position
37% Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $20 › 200d $21 — 200d above 50d
Institutional flow Accumulating
+30% holders QoQ · +72 funds added
Insider flow Accumulating
Net +$502.8K over 90 days · 0% sells
Short interest Rising
3.66% of float · ▲ +9.4% MoM · 4.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
191 holders — 13F breadth
Price context
position in its available closing range
Range low $14 Now $22 · 37% Range high $37
vs 200-day avg +8% vs 50-day avg +9%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Aerospace & Defense — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
BETA
BETA Technologies, Inc.
this stock
$5.19B -21.3% +136.0% 3.7%
SPCX
Space Exploration Technologies Corp
$1.97T 1.4%
GE
General Electric Co
$346.69B +9.4% +18.5% 39.4 1.3%
RTX
RTX Corp
$272.42B +9.5% +17.1% 35.6 1.0%
EADSF
Airbus SE/ADR
$179.80B -2.4% 0.1%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
191
% held
49.4%
Net QoQ
+7.2M sh
Top holder
FMR LLC
Held Float
View
Held by Funds
Fund positions
163
View
Short & Settlement
Short Interest Rising
Shares short
8.6M
Days to cover
4.0d
Change
+737.7K sh
View
Short Volume
Short vol %
57%
As of
Sep 4, 2026
Short Total
View
Fails to Deliver
FTD shares
193
Value
$4.5K
As of
Aug 10, 2026
View
Off-Exchange
Off-exchange %
45.7%
Week of
Jul 27, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net buying
Net (90d)
+$502.8K
Buyers / Sellers
1 / 0
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$35.6M
Net income (FY)
$-745.9M
EPS diluted
$-12.85
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 12, 2026
This year
11
View
Proposed Sales
Value
$585.3K
Shares
23.2K
Filed
Aug 21, 2026
View
Exempt Offerings
Offering
$13.0M
Filed
Apr 16, 2026
View
Earnings & Events
Earnings Calls
Last call
Aug 12, 2026
View

Performance

5D 20D 120D MTD YTD
BETA +10.1% -5.6% +31.8% +10.5% -21.3%
SPY +0.1% -0.4% +15.1% +0.4% +12.9%
vs SPY +10.0% -5.2% +16.6% +10.0% -34.2%
Key facts CIK 1784570 CUSIP 086921103 13F (30d) 146 filings 144 filers Visit website Investor relations